29.09.2015 • NewsDede WillamsspinoffAshland

Ashland to Spin off Valvoline to Shareholders

US chemical producer Ashland has announced it will spin off its engine lubricants subsidiary Valvoline in a tax-free transaction to shareholders. The separation is expected to take at least a year to complete.

Going forward, the lubricants business will be publicly listed, and Ashland will consist solely of its Specialty Ingredients and Performance Materials segments, which had sales of around $3.6 billion in fiscal 2015, which ended on Jun. 30.

In a statement, the company to be headed by William Wulfsohn as chairman and current senior vice president Luis Fernandez-Moreno as CEO, said the spinoff is the final step in its decades-long shift from an oil refiner to a specialty chemicals manufacturer.

In July of this year, Ashland completed the sale of Valvoline’s car-care products to Niteo, a subsidiary of private equity firm Highlander Partners. This business represented less than 4% of Valvoline's $2 billion annual sales.

In late May, Ashland announced plans to sell the industrial biocides assets – about 2% of the Specialty Ingredients segment’s sales – to Troy Corporation, a global leader in microbial control products and performance additives. Financial terms were not disclosed.

The specialty chemicals producer had recently been under pressure from activist investor Jana Partners to trim assets and boost its share price. Jana exited the company in May of this year.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.